Scholar Rock Holding (SRRK) Property, Plant & Equipment (Net) Growth (3y) (2020 - 2026)
Scholar Rock Holding (SRRK) Property, Plant & Equipment (Net) Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PP&E (Net) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-14.40% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
3.41% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
13.10% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Scholar Rock Holding |
5.62 Bn |
5.14 Bn |
- |
-40.11% |
| Date | Value |
|---|
| Mar 31, 2026 |
-40.11% |
| Dec 31, 2025 |
-38.65% |
| Sep 30, 2025 |
-36.18% |
| Jun 30, 2025 |
-34.69% |
| Mar 31, 2025 |
-34.65% |
| Dec 31, 2024 |
-33.91% |
| Sep 30, 2024 |
-30.85% |
| Jun 30, 2024 |
-27.81% |
| Mar 31, 2024 |
-23.23% |
| Dec 31, 2023 |
-17.26% |
| Sep 30, 2023 |
-1.63% |
| Jun 30, 2023 |
17.53% |
| Mar 31, 2023 |
18.52% |
| Dec 31, 2022 |
20.97% |
| Sep 30, 2022 |
23.61% |
| Jun 30, 2022 |
36.08% |
| Mar 31, 2022 |
37.43% |
| Dec 31, 2021 |
44.19% |
| Sep 30, 2021 |
53.76% |
| Jun 30, 2021 |
71.93% |
